1
|
Van Den Berg G, De Van Der Schueren M, Vermeulen H, Huisman - De Waal G. Patients’ Experiences With Malnutrition Care In The Perioperative Period Of Hospitalization And Perceived Needs And Opportunities For Patient Participation; A Qualitative Study. Clin Nutr ESPEN 2023. [DOI: 10.1016/j.clnesp.2022.09.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/28/2023]
|
2
|
De Roeck L, Spiessens P, Vermeulen H, Clement P, Daisne J, De Vleeschouwer S, Sleurs C, Lambrecht M. P01.09.A Prevalence and predictors of cognitive impairment in adult glioma survivors after multimodal therapy. Neuro Oncol 2022. [DOI: 10.1093/neuonc/noac174.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Long-term survival can be achieved in an increasing number of glioma patients after treatment. Therefore, safeguarding these survivors’ quality of life (QoL) is essential. Neurocognitive decline arises in many young patients, placing a heavy burden on the social and economic aspects of the patients’ lives. A lot of debate is currently ongoing regarding the prevalence of neurocognitive impairment and individual predictors of whom is susceptible for such side effect.
Material and Methods
In this cross-sectional study, 37 WHO grade 2-3 adult glioma survivors, at least one year after multimodal therapy, were tested using a comprehensive neurocognitive test battery covering multiple cognitive domains. Neurocognitive test scores were converted into z-scores using country-specific normative data. Cognitive impairment was defined as a z-score lower or equal to -1.50 for each subtest. Age, time since multimodal therapy, radiotherapy treatment and tumour location were included as predictors in a linear regression model per outcome (n=12).
Results
In this cohort, 29 patients (78%) showed a test score below the predefined cutoff on at least one cognitive test. The percentage of patients who showed test-specific cognitive impairment ranged from 8.1% to 56.76% per test. Fine motor skills, verbal memory, processing speed and executive functioning were the most commonly affected cognitive domains. In this study, the variability in processing speed performance was associated with age (TMT A, p=0.03), time since therapy (WAIS-IV coding, p=0.02) and tumour location. In these measures, poorer outcomes were observed with increasing age, longer time since therapy and in patients with gliomas located in the left frontal lobe. Moreover, age showed to be a significant predictor of verbal memory, with poorer outcomes on the HVLT-R delayed recall task with increasing age (p=0.04). Tumour location predicted working memory performance, as patients with right parietal tumours (p=0.03) showed significantly worse on the WAIS-IV digit span task.
Conclusion
These preliminary data underline the various alterations of neurocognitive functioning in glioma survivors after multimodal therapy. Therefore, future research needs to shift towards a patient-tailored approach. The next step in this study will be to link these neurocognitive data to advanced neuroimaging data to explore the potential predictive value of imaging markers for neural damage and cognitive outcomes, paving the path to innovative treatment planning techniques.
Collapse
Affiliation(s)
- L De Roeck
- Department of Radiation Oncology, University Hospitals Leuven , Leuven , Belgium
- Laboratory of Experimental Radiotherapy, KU Leuven , Leuven , Belgium
| | - P Spiessens
- Department of Psychology, KU Leuven , Leuven , Belgium
| | - H Vermeulen
- Department of Psychology, KU Leuven , Leuven , Belgium
| | - P Clement
- Department of Oncology, University Hospitals Leuven , Leuven , Belgium
- Department of Oncology, KU Leuven , Leuven , Belgium
| | - J Daisne
- Department of Radiation Oncology, University Hospitals Leuven , Leuven , Belgium
- Laboratory of Experimental Radiotherapy, KU Leuven , Leuven , Belgium
| | - S De Vleeschouwer
- Department of Neurosurgery, University Hospitals Leuven , Leuven , Belgium
- Leuven Brain Institute, KU Leuven , Leuven , Belgium
| | - C Sleurs
- Department of Oncology, KU Leuven , Leuven , Belgium
- Leuven Brain Institute, KU Leuven , Leuven , Belgium
| | - M Lambrecht
- Department of Radiation Oncology, University Hospitals Leuven , Leuven , Belgium
- Laboratory of Experimental Radiotherapy, KU Leuven , Leuven , Belgium
| |
Collapse
|
3
|
Van Noort H, Vermeulen H, Lamers C, Huisman-de Waal G, Witteman B. Implementation of anaesthetic fasting guidelines in upper abdominal endoscopy to shorten fasting times: a controlled pilot study. Clin Nutr ESPEN 2021. [DOI: 10.1016/j.clnesp.2021.09.579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
4
|
van den Brink GTWJ, Hooker RS, Van Vught AJ, Vermeulen H, Laurant MGH. The cost-effectiveness of physician assistants/associates: A systematic review of international evidence. PLoS One 2021; 16:e0259183. [PMID: 34723999 PMCID: PMC8559935 DOI: 10.1371/journal.pone.0259183] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Accepted: 10/14/2021] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND The global utilization of the physician assistant/associate (PA) is growing. Their increasing presence is in response to the rising demands of demographic changes, new developments in healthcare, and physician shortages. While PAs are present on four continents, the evidence of whether their employment contributes to more efficient healthcare has not been assessed in the aggregate. We undertook a systematic review of the literature on PA cost-effectiveness as compared to physicians. Cost-effectiveness was operationalized as quality, accessibility, and the cost of care. METHODS AND FINDINGS Literature to June 2021 was searched across five biomedical databases and filtered for eligibility. Publications that met the inclusion criteria were categorized by date, country, design, and results by three researchers independently. All studies were screened with the Risk of Bias in Non-randomised Studies-of Interventions (ROBIN-I) tool. The literature search produced 4,855 titles, and after applying criteria, 39 studies met inclusion (34 North America, 4 Europe, 1 Africa). Ten studies had a prospective design, and 29 were retrospective. Four studies were assessed as biased in results reporting. While most studies included a small number of PAs, five studies were national in origin and assessed the employment of a few hundred PAs and their care of thousands of patients. In 34 studies, the PA was employed as a substitute for traditional physician services, and in five studies, the PA was employed in a complementary role. The quality of care delivered by a PA was comparable to a physician's care in 15 studies, and in 18 studies, the quality of care exceeded that of a physician. In total, 29 studies showed that both labor and resource costs were lower when the PA delivered the care than when the physician delivered the care. CONCLUSIONS Most of the studies were of good methodological quality, and the results point in the same direction; PAs delivered the same or better care outcomes as physicians with the same or less cost of care. Sometimes this efficiency was due to their reduced labor cost and sometimes because they were more effective as producers of care and activity.
Collapse
Affiliation(s)
- G. T. W. J. van den Brink
- Radboud Institute for Health Sciences, IQ healthcare, Radboud University Medical Center, Nijmegen, The Netherlands
- HAN University of Applied Sciences, School of Health Studies, Nijmegen, The Netherlands
| | - R. S. Hooker
- Adjunct Professor, Health Policy, Northern Arizona University, United States of America
| | - A. J. Van Vught
- HAN University of Applied Sciences, School of Health Studies, Nijmegen, The Netherlands
| | - H. Vermeulen
- Radboud Institute for Health Sciences, IQ healthcare, Radboud University Medical Center, Nijmegen, The Netherlands
- HAN University of Applied Sciences, School of Health Studies, Nijmegen, The Netherlands
| | - M. G. H. Laurant
- Radboud Institute for Health Sciences, IQ healthcare, Radboud University Medical Center, Nijmegen, The Netherlands
- HAN University of Applied Sciences, School of Health Studies, Nijmegen, The Netherlands
| |
Collapse
|
5
|
Hoegen P, de Bot C, Echteld M, Vermeulen H. Measuring self-efficacy and outcome expectancy in evidence-based practice: A systematic review on psychometric properties. International Journal of Nursing Studies Advances 2021. [DOI: 10.1016/j.ijnsa.2021.100024] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
6
|
van den Brink GTWJ, Kouwen AJ, Hooker RS, Vermeulen H, Laurant MGH. An activity analysis of Dutch hospital-based physician assistants and nurse practitioners. Hum Resour Health 2019; 17:78. [PMID: 31665010 PMCID: PMC6819603 DOI: 10.1186/s12960-019-0423-z] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/05/2019] [Accepted: 09/24/2019] [Indexed: 06/10/2023]
Abstract
BACKGROUND The physician assistant (PA) and the nurse practitioner (NP) were introduced into The Netherlands in 2001 and 1997 respectively. By the second decade, national policies had accelerated the acceptance and development of these professions. Since 2015, the PA and NP have full practice authority as independent health professionals. The aim of this research was to gain a better understanding of the tasks and responsibilities that are being shifted from Medical Doctors (MD) to PAs and NPs in hospitals. More specifically in what context and visibility are these tasks undertaken by hospital-based PAs and NPs in patient care. This will enable them to communicate their worth to the hospital management. STUDY DESIGN A descriptive, non-experimental research method design was used to collect and analyze both quantitative and qualitative data about the type of tasks performed by a PA or NP. Fifteen medical departments across four hospitals participated. METHODS The patient scheduling system and hospital information system were probed to identify and characterize a wide variety of clinical tasks. The array of tasks was further verified by 108 interviews. All tasks were divided into direct and indirect patient care. Once the tasks were cataloged, then MDs and hospital managers graded the PA- or NP-performed tasks and assessed their contributions to the hospital management system. FINDINGS In total, 2883 tasks were assessed. Overall, PAs and NPs performed a wide variety of clinical and administrative tasks, which differed across hospitals and medical specialties. Data from interviews and the hospital management systems revealed that over a third of the tasks were not properly registered or attributed to the PA or NP. After correction, it was found that the NP and PA spent more than two thirds of their working time on direct patient care. CONCLUSIONS NPs and PAs performed a wide variety of clinical tasks, and the consistency of these tasks differed per medical specialty. Despite the fact that a large part of the tasks was not visible due to incorrect administration, the interviews with MDs and managers revealed that the use of an NP or PA was considered to have an added value at the quality of care as well to the production for hospital-based medical care in The Netherlands.
Collapse
Affiliation(s)
- G T W J van den Brink
- Radboud Institute for Health Sciences, IQ healthcare, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Master Programs, HAN University of Applied Sciences, PO box 6960, 6503 GL, Nijmegen, The Netherlands.
| | - A J Kouwen
- Radboud University Medical Center, PVI, Nijmegen, The Netherlands
| | - R S Hooker
- Health Policy Analyst, Ridgefield, WA, United States of America
| | - H Vermeulen
- Radboud Institute for Health Sciences, IQ healthcare, Radboud University Medical Center, Nijmegen, The Netherlands
| | - M G H Laurant
- Radboud Institute for Health Sciences, IQ healthcare, Radboud University Medical Center, Nijmegen, The Netherlands
- HAN University of Applied Sciences, Institute of Nursing Studies, Nijmegen, The Netherlands
| |
Collapse
|
7
|
Koop Y, Maas AHEM, Vermeulen H, Atsma F. 4117Cardiac surveillance during breast cancer treatment; a snapshot of current practice. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Breast cancer (BC) is the most common type of cancer in women. Over the past decades survival rates increased up to 90% at 5 years and 83% at 10 years. The various BC treatments, such as radiotherapy, chemotherapy and immunotherapy increase cardiotoxicity risk, leading to premature ischemic heart disease and heart failure amongst survivors. Both affect women's daily routine and quality of life. Reducing this adverse risk, by early recognition and (preventive) treatment, is therefore important. Despite, screening for cardiotoxicity is currently insufficiently standardized in daily practice.
A fundamental step in identifying areas of improvement is providing an overview of current practice.
Purpose
This study aims to describe current cardiac surveillance for women with BC during and after cancer treatment, using routinely collected hospital data in the Netherlands.
Methods
An observational study has been performed on Dutch hospital data from 2012 up to 2015, provided by Statistics Netherlands. Information about cardiology and oncology diagnoses, diagnostic procedures, treatments and preventive measures were available. Newly diagnosed female patients with codes malignant neoplasm of the breast (ICD-10, C50.0-C50.9) in 2013 and without any comorbidities since 1–1-2012 were included in the analyses. In follow-up data up to 31–12 2015, we mapped all types of care the patients received for BC and cardiology related indications.
Results
We included 16040 newly diagnosed BC patients in 2013, with a mean age of 65.9 (sd 12.9). A total of 5084 (31.7%) received chemotherapy, 1385 (8.6%) immunotherapy and 7870 (49.1%) radiotherapy. Amongst all included patients, 4376 (27.3%) received any type of cardiac care. Cardiology specific laboratory tests (e.g. Troponin) were performed in 96 (0.6%). Imaging procedures, such as echocardiography and MUGA occurred in 1853 (11.5%) and 1544 (9.6%) patients, respectively.
Of the 5084 patients receiving chemotherapy 1862 (36.6%) received any type of imaging or cardiac care, of the 1385 patients receiving immunotherapy 689 (49.7%), and of the 7870 patients receiving radiotherapy 2401 (31.7%).
Conclusions
This study shows that only a quarter of Dutch women treated for BC receive cardiac surveillance. Diagnostic procedures or laboratory tests to detect cardiotoxicity are not structurally performed in women receiving cardiotoxic cancer treatments (e.g. chemo- and radiotherapy). A more structural approach and individual risk assessment is needed to provide more tailored cardiac care during BC treatment.
Collapse
Affiliation(s)
- Y Koop
- Radboud University Medical Centre, Nijmegen, Netherlands (The)
| | - A H E M Maas
- Radboud University Medical Centre, Nijmegen, Netherlands (The)
| | - H Vermeulen
- Radboud University Medical Centre, Nijmegen, Netherlands (The)
| | - F Atsma
- Radboud University Medical Centre, Nijmegen, Netherlands (The)
| |
Collapse
|
8
|
Vink P, Lucas C, Maaskant JM, van Erp WS, Lindeboom R, Vermeulen H. Clinimetric properties of the Nociception Coma Scale (-Revised): A systematic review. Eur J Pain 2017; 21:1463-1474. [PMID: 28573825 PMCID: PMC5600098 DOI: 10.1002/ejp.1063] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/01/2017] [Indexed: 11/12/2022]
Abstract
The Nociception Coma Scale is a nociception behaviour observation tool, developed specifically for patients with disorders of consciousness (DOC) due to (acquired) brain injury. Over the years, the clinimetric properties of the NCS and its revised version (NCS‐R) have been assessed, but no formal summary of these properties has been made. Therefore, we performed a systematic review on the clinimetric properties (i.e. reliability, validity, responsiveness and interpretability) of the NCS(‐R). We systematically searched CENTRAL, CINAHL, Embase, PsycInfo and Web of Science until August 2015. Two reviewers independently selected the clinimetric studies and extracted data with a structured form. Included studies were appraised on quality with the COSMIN checklist. Eight studies were found eligible and were appraised with the COSMIN checklist. Although nearly all studies lacked sample size calculation, and were executed by the same group of authors, the methodological quality ranged from fair to excellent. Important aspects of reliability, construct validity and responsiveness have been studied in depth and with sufficient methodological quality. The overview of clinimetric properties in this study shows that the NCS and NCS‐R are both valid and useful instruments to assess nociceptive behaviour in DOC patients. The studies provide guidance for the choice in NCS‐R cut‐off value for possible pain treatment and cautions awareness of interprofessional differences in NCS‐R measurements. Significance This systematic review provides a structured overview of the clinimetric properties of the Nociception Coma Scale (‐Revised) and provides insights for a solid evidence‐based nociception behaviour assessment and treatment plan.
Collapse
Affiliation(s)
- P Vink
- Department of Neurology and Neurosurgery, Academic Medical Center (AMC), Amsterdam, The Netherlands.,Omni Cura Nursing Teaching Research, Amsterdam, The Netherlands
| | - C Lucas
- Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Medical Faculty (AMC), University of Amsterdam, The Netherlands
| | - J M Maaskant
- Emma Children's Hospital, Academic Medical Center Amsterdam, The Netherlands.,ACHIEVE Centre of Applied Research, Faculty of Health, Amsterdam University of Applied Sciences, The Netherlands
| | - W S van Erp
- Department of Primary and Community Care, Centre for Family Medicine, Geriatric Care and Public Health, Radboud University Medical Centre, Nijmegen, The Netherlands.,Coma Science Group, Cyclotron Research Center and Neurology Department, University of Liège, Belgium
| | - R Lindeboom
- Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Medical Faculty (AMC), University of Amsterdam, The Netherlands
| | - H Vermeulen
- Department of Surgery, Academic Medical Center (AMC), Amsterdam, The Netherlands.,Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ Healthcare), Nijmegen, The Netherlands
| |
Collapse
|
9
|
Berings M, Jult A, Vermeulen H, De Ruyck N, Derycke L, Ucar H, Ghekiere P, Temmerman R, Ellis J, Bachert C, Lambrecht BN, Dullaers M, Gevaert P. Probiotics-impregnated bedding covers for house dust mite allergic rhinitis: A pilot randomized clinical trial. Clin Exp Allergy 2017; 47:1092-1096. [DOI: 10.1111/cea.12937] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- M. Berings
- Upper Airways Research Laboratory; Ghent University; Ghent Belgium
- Laboratory of Immunoregulation; VIB Inflammation Research Center; Ghent Belgium
| | - A. Jult
- Ghent University; Ghent Belgium
| | | | - N. De Ruyck
- Upper Airways Research Laboratory; Ghent University; Ghent Belgium
| | - L. Derycke
- Upper Airways Research Laboratory; Ghent University; Ghent Belgium
| | - H. Ucar
- BekaertDeslee Innovation bvba; Waregem Belgium
| | - P. Ghekiere
- BekaertDeslee Innovation bvba; Waregem Belgium
| | | | - J. Ellis
- Devan Chemicals NV; Ronse Belgium
| | - C. Bachert
- Upper Airways Research Laboratory; Ghent University; Ghent Belgium
| | - B. N. Lambrecht
- Laboratory of Immunoregulation; VIB Inflammation Research Center; Ghent Belgium
- Department of Internal Medicine; Ghent University; Ghent Belgium
| | - M. Dullaers
- Laboratory of Immunoregulation; VIB Inflammation Research Center; Ghent Belgium
- Department of Internal Medicine; Ghent University; Ghent Belgium
- Clinical Immunology Research Lab; Department of Respiratory Medicine; Ghent University Hospital; Ghent Belgium
| | - P. Gevaert
- Upper Airways Research Laboratory; Ghent University; Ghent Belgium
| |
Collapse
|
10
|
Maaskant J, Raymakers-Janssen P, Veldhoen E, Ista E, Lucas C, Vermeulen H. The clinimetric properties of the COMFORT scale: A systematic review. Eur J Pain 2016; 20:1587-1611. [PMID: 27161119 DOI: 10.1002/ejp.880] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/18/2016] [Indexed: 11/08/2022]
Abstract
The COMFORT scale is a measurement tool to assess distress, sedation and pain in nonverbal paediatric patients. Several studies have described the COMFORT scale, but no formal assessment of the methodological quality has been undertaken. Therefore, we performed a systematic review to study the clinimetric properties of the (modified) COMFORT scale in children up to 18 years. We searched Central, CINAHL, Embase, Medline, PsycInfo and Web of Science until December 2014. The selection, data extraction and quality assessment were performed independently by two reviewers. Quality of the included studies was appraised using the COSMIN checklist. We found 30 studies that met the inclusion criteria. Most participants were ventilated children up to 4 years without neurological disorders. The results on internal consistency and interrater reliability showed values of >0.70 in most studies, indicating an adequate reliability. Construct validity resulted in correlations between 0.68 and 0.84 for distress, between 0.42 and 0.94 for sedation and between 0.31 and 0.96 for pain. The responsiveness of the (modified) COMFORT scale seems to be adequate. The quality of the included studies ranged from poor to excellent. The COMFORT scale shows overall an adequate reliability in providing information on distress, sedation and pain. Construct validity varies from good to excellent for distress, from moderate to excellent for sedation, and from poor to excellent for pain. The included studies were clinically and methodologically heterogeneous, hampering firm conclusions. WHAT DOES THIS REVIEW ADD?: An in-depth assessment of the clinimetric properties of the COMFORT scale. The COMFORT scale shows overall an adequate reliability in providing information on distress, sedation and pain. Construct validity varies from good to excellent for distress, from moderate to excellent for sedation, and from poor to excellent for pain.
Collapse
Affiliation(s)
- J Maaskant
- Emma Children's Hospital, Academic Medical Center Amsterdam, The Netherlands. .,Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, The Netherlands.
| | - P Raymakers-Janssen
- Pediatric Intensive Care Unit, Wilhelmina Children's Hospital, University Medical Center Utrecht, The Netherlands
| | - E Veldhoen
- Pediatric Intensive Care Unit, Wilhelmina Children's Hospital, University Medical Center Utrecht, The Netherlands
| | - E Ista
- Intensive Care Unit, Department of Pediatrics and Pediatric Surgery, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands
| | - C Lucas
- Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, The Netherlands
| | - H Vermeulen
- Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands.,Amsterdam School of Health Professions, Amsterdam, The Netherlands
| |
Collapse
|
11
|
Abstract
In deze casus wordt een vermoedelijk kwaadwillige, orale ivermectine-intoxicatie op een Vlaams vleeskalverbedrijf besproken. Alle 330 kalveren van twee tot vier weken oud werden in de eerste week na aankomst op het bedrijf getroffen. De symptomen waren ernstige depressie, het neerliggen in laterale of sternale positie, tremor en kopschudden. Uiteindelijk stierf 13,6% van de kalveren. De overige dieren herstelden gradueel met ondersteunende orale rehydratatietherapie over een termijn van vijf tot zeven dagen. In de kunstmelk kon een ivermectinegehalte van 35 mg/kg aangetoond worden. In het serum van drie kalveren werden ivermectinegehaltes van 0,75 mg/kg tot 1,1 mg/kg gevonden. De vermoedelijk toegediende dosering was 1,75 mg/kg lichaamsgewicht voor een gemiddeld kalf (40 kg). In deze casus wordt aangetoond dat orale toxiciteitsverschijnselen van ivermectine bij kalveren van twee tot vier weken oud kunnen optreden aan een dosis die 8,75 keer hoger is dan de geregistreerde therapeutische dosis voor subcutane toediening bij rundvee.
Collapse
|
12
|
Eijsvoogel CFH, Peters RW, Budding AJ, Ubbink DT, Vermeulen H, Schep NWL. Implementation of an acute surgical admission ward. Br J Surg 2014; 101:1434-8. [DOI: 10.1002/bjs.9605] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2014] [Revised: 05/19/2014] [Accepted: 06/06/2014] [Indexed: 11/10/2022]
Abstract
Abstract
Background
The aim of the study was to assess the impact of an acute surgical admission ward on admission and discharge processes.
Methods
This prospective cohort study was conducted in a university tertiary referral centre. All acute surgical patients were clustered in the acute surgical unit (ASU) in February and March 2012, and discharged or transferred to specialized departments within 48 h. The primary outcome was length of hospital stay (LOS). Secondary outcomes were impact on emergency department waiting times, discharge home within 48 h, incorrect ward admissions, readmissions and mortality. Outcomes of the study group were compared with those of a historical reference group admitted during the same interval the year before.
Results
Some 249 patients were admitted to the ASU during the study interval. The reference group consisted of 211 patients. The total LOS decreased significantly from a median of 4·0 to 2·0 days (P = 0·004). The percentage of patients who were discharged within 48 h increased from 30·3 to 43·4 per cent (P = 0·004). The rate of incorrect ward admission decreased from 9·5 to 0 per cent. Emergency department waiting time, readmission rate and 30-day mortality did not change.
Conclusion
Introduction of an acute surgical unit-shortened length of hospital stay without comprising readmission and mortality rates.
Collapse
Affiliation(s)
- C F H Eijsvoogel
- Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands
| | - R W Peters
- Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands
| | - A J Budding
- Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands
| | - D T Ubbink
- Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands
- Department of Quality Assurance and Process Innovation, Academic Medical Centre, Amsterdam, The Netherlands
| | - H Vermeulen
- Department of Quality Assurance and Process Innovation, Academic Medical Centre, Amsterdam, The Netherlands
| | - N W L Schep
- Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands
| |
Collapse
|
13
|
Brölmann FE, Eskes AM, Goslings JC, Niessen FB, de Bree R, Vahl AC, Pierik EG, Vermeulen H, Ubbink DT. Randomized clinical trial of donor-site wound dressings after split-skin grafting. Br J Surg 2013; 100:619-27. [DOI: 10.1002/bjs.9045] [Citation(s) in RCA: 63] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/14/2012] [Indexed: 11/11/2022]
Abstract
Abstract
Background
The aim was to study which dressing material was best for healing donor-site wounds (DSWs) after split-skin grafting as there is wide variation in existing methods, ranging from classical gauze dressings to modern silicone dressings.
Methods
This 14-centre, six-armed randomized clinical trial (stratified by centre) compared six wound dressing materials in adult patients with DSWs larger than 10 cm2. Primary outcomes were time to complete re-epithelialization and pain scores measured on a visual analogue scale (VAS) over 4 weeks. Secondary outcomes included itching (VAS, over 4 weeks), adverse events and scarring after 12 weeks rated using the Patient and Observer Scar Assessment Scale (POSAS).
Results
Between October 2009 and December 2011, 289 patients were randomized (of whom 288 were analysed) to either alginate (45), film (49), gauze (50), hydrocolloid (49), hydrofibre (47) or silicone (48) dressings. Time to complete re-epithelialization using hydrocolloid dressings was 7 days shorter than when any other dressing was used (median 16 versus 23 days; P < 0·001). Overall pain scores were low, and slightly lower with use of film dressings (P = 0·038). The infection rate among patients treated with gauze was twice as high as in those who had other dressings (18 versus 7·6 per cent; relative risk 2·38, 95 per cent confidence interval 1·14 to 4·99). Patients who had a film dressing were least satisfied with overall scar quality.
Conclusion
This trial showed that use of hydrocolloid dressings led to the speediest healing of DSWs. Gauze dressing should be discontinued as they caused more infections. Registration number: NTR1849 (http://www.trialregister.nl).
Collapse
Affiliation(s)
- F E Brölmann
- Department of Quality Assurance and Process Innovation, The Netherlands
| | - A M Eskes
- Department of Quality Assurance and Process Innovation, The Netherlands
- Amsterdam School of Health Professions, The Netherlands
| | - J C Goslings
- Trauma Unit, Department of Surgery, Academic Medical Centre, University of Amsterdam, The Netherlands
| | - F B Niessen
- Department of Plastic and Reconstructive Surgery, The Netherlands
| | - R de Bree
- Department of Otolaryngology/Head and Neck Surgery, VU University Medical Centre, The Netherlands
| | - A C Vahl
- Department of Vascular Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
| | - E G Pierik
- Department of Surgery, Isala Klinieken, Zwolle, The Netherlands
| | - H Vermeulen
- Department of Quality Assurance and Process Innovation, The Netherlands
- Amsterdam School of Health Professions, The Netherlands
| | - D T Ubbink
- Department of Quality Assurance and Process Innovation, The Netherlands
- Trauma Unit, Department of Surgery, Academic Medical Centre, University of Amsterdam, The Netherlands
| |
Collapse
|
14
|
Ubbink DT, Vermeulen H, Knops AM, Legemate DA, Oude Rengerink K, Heineman MJ, Roos YB, Fijnvandraat CJ, Heymans HS, Simons R, Levi M. Implementation of evidence-based practice: outside the box, throughout the hospital. Neth J Med 2011; 69:87-94. [PMID: 21411849] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
BACKGROUND Evidence-based practice (EBP) is a generally accepted means to improve healthcare quality. However, not all healthcare professionals and managers apply EBP in daily practice. We investigated EBP attitudes, knowledge and the perceived barriers and facilitators to practising EBP , to define tailor-made interventions for improving evidence-based behaviour. METHODS In this cross-sectional survey, doctors and nurses from five major specialities of a university hospital were invited to complete the McColl and Barriers questionnaires. RESULTS Response rates were 70% (305÷435) for doctors and 74% (396÷537) for nurses. They were welcoming towards EBP, but considered time constraints, knowledge gaps and poor availability of evidence as major barriers to implement EBP . They also mentioned contradicting results (75%) and flawed methodology (69%), while nurses frequently mentioned unawareness of (75%), or difficulty in reading and interpreting research papers (70%). Regarding EBP knowledge, 6/8 common EBP terms could be explained by 54% of doctors but by only 15% of nurses. Facilitating factors among doctors concerned the availability and accessibility of high-level evidence and communication of evidence during various clinical meetings and handovers for clinical decision making. Among nurses, promoting factors involved more teaching and instances to incorporate EBP in clinical practice. Both groups desired more managerial support in terms of motivation and opportunities. CONCLUSIONS Doctors and nurses have embraced the EBP paradigm as an important means to improve quality of clinical patient care, but its application is still cumbersome. This paper offers a tailored programme for implementation and managerial role-models.sustainment of EBP, corroborated by professional and managerial role-models.
Collapse
Affiliation(s)
- D T Ubbink
- Department of Quality Assurance & Process Innovation, University of Amsterdam, the Netherlands.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Vermeulen H, Westerbos S, Ubbink D. Benefit and harm of iodine in wound care: a systematic review. J Hosp Infect 2010; 76:191-9. [DOI: 10.1016/j.jhin.2010.04.026] [Citation(s) in RCA: 93] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2009] [Accepted: 04/23/2010] [Indexed: 11/28/2022]
|
16
|
|
17
|
|
18
|
Schönfeldt HC, Gibson N, Vermeulen H. NEWS AND VIEWS: The possible impact of inflation on nutritionally vulnerable households in a developing country using South Africa as a case study. NUTR BULL 2010. [DOI: 10.1111/j.1467-3010.2010.01837.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
19
|
Knops AM, Storm-Versloot MN, Mank APM, Ubbink DT, Vermeulen H, Bossuyt PMM, Goossens A. Factors influencing long-term adherence to two previously implemented hospital guidelines. Int J Qual Health Care 2010; 22:421-9. [PMID: 20716551 DOI: 10.1093/intqhc/mzq038] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
OBJECTIVE AND SETTING After successful implementation, adherence to hospital guidelines should be sustained. Long-term adherence to two hospital guidelines was audited. The overall aim was to explore factors accounting for their long-term adherence or non-adherence. DESIGN AND PARTICIPANTS A fluid balance guideline (FBG) and body temperature guideline (BTG) were developed and implemented in our hospital in 2000. Long-term adherence was determined retrospectively based on data from patient files. Focus groups were launched to explore nurses' perceptions of barriers and facilitators regarding long-term adherence. The predominant themes from the nurses' focus groups were posed to clinicians in questionnaires. RESULTS Nurses involved in the FBG (overall adherence 100%) stated that adherence has immediate advantages in terms of safety and a gain in time. Nurses and oncologists acted unanimously which was thought to enhance adherence. On the other hand, opinions differed on the BTG within the nursing teams and medical staff (overall adherence 50%). Although the guideline discourages routine postoperative body temperature measurements, temperature should be measured according to the guideline in a considerable number of cases due to changes in patient characteristics since the year 2000. Therefore, adherence was judged to be rather complex. CONCLUSIONS To secure adherence to hospital guidelines after their successful implementation, guidelines should preferably be comprehensive in terms of being applicable to the majority of the patients in that particular setting and to the most common clinical situations. All healthcare professionals involved should be aware of its immediate benefits for themselves or to their patients.
Collapse
Affiliation(s)
- A M Knops
- Department of Quality Assurance and Process Innovation, Academic Medical Center, Room A3-503, PO Box 22660, 1100 DD Amsterdam, The Netherlands.
| | | | | | | | | | | | | |
Collapse
|
20
|
Ubbink D, Vermeulen H. The challenge of using randomized trials in wound healing (Br J Surg 2010; 97: 303–304). Br J Surg 2010; 97:1147; author reply 1147-8. [DOI: 10.1002/bjs.7165] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- D Ubbink
- Academic Medical Centre, Amsterdam, The Netherlands
| | - H Vermeulen
- Academic Medical Centre, Amsterdam, The Netherlands
| |
Collapse
|
21
|
Ubbink DT, Vermeulen H, Legemate DA. Comment on: "Negative pressure wound therapy: a systematic review of effectiveness and safety", P. Vikatmaa, V. Juutilainen, P. Kuukasjärvi, A. Malmivaara, Eur J Vasc Endovasc Surg 2008;36(4):438-48. Eur J Vasc Endovasc Surg 2009; 37:740-1; author reply 741-2. [PMID: 19328731 DOI: 10.1016/j.ejvs.2009.01.018] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2008] [Accepted: 01/07/2009] [Indexed: 11/28/2022]
|
22
|
Ubbink DT, Westerbos SJ, Nelson EA, Vermeulen H. Authors' reply: A systematic review of topical negative pressure therapy for acute and chronic wounds (Br J Surg 2008; 95: 685–692). Br J Surg 2008. [DOI: 10.1002/bjs.6363] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- D T Ubbink
- Department of Quality Assurance and Process Innovation, Academic Medical Centre, Meibergdreef 9, Room J1B-215, PO Box 22700, 1100 DE Amsterdam, The Netherlands
| | - S J Westerbos
- Department of Quality Assurance and Process Innovation, Academic Medical Centre, Meibergdreef 9, Room J1B-215, PO Box 22700, 1100 DE Amsterdam, The Netherlands
| | - E A Nelson
- Department of Quality Assurance and Process Innovation, Academic Medical Centre, Meibergdreef 9, Room J1B-215, PO Box 22700, 1100 DE Amsterdam, The Netherlands
| | - H Vermeulen
- Department of Quality Assurance and Process Innovation, Academic Medical Centre, Meibergdreef 9, Room J1B-215, PO Box 22700, 1100 DE Amsterdam, The Netherlands
| |
Collapse
|
23
|
Ubbink DT, Westerbos SJ, Nelson EA, Vermeulen H. A systematic review of topical negative pressure therapy for acute and chronic wounds. Br J Surg 2008; 95:685-92. [PMID: 18446777 DOI: 10.1002/bjs.6238] [Citation(s) in RCA: 177] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
BACKGROUND Topical negative pressure (TNP) therapy is becoming increasingly popular for all kinds of wounds. Its clinical and cost effectiveness is unclear. METHODS A search of randomized controlled trials (RCTs) on TNP in adult patients with all kinds of wounds in all settings was undertaken in Medline, Embase, Cinahl (to October 2007) and the Cochrane Library (to issue 4, 2007). Information was also sought from manufacturer of the VAC device. Selection of trials for analysis, quality assessment, data abstraction and data synthesis were conducted by two authors independently. The primary endpoint was any measure of wound healing. Secondary endpoints were infection, pain, quality of life, oedema, microcirculation, bacterial load, adverse events, duration of hospital stay and cost. RESULTS The search identified 15 publications on 13 RCTs. These reported on patients with chronic wounds, diabetic wounds, pressure ulcers, skin grafts and acute wounds. In chronic and diabetic wounds, TNP did not allow earlier complete wound healing. It was, however, associated with a 1-10 day reduction in the time needed to prepare the wound for secondary closure surgery. In one trial on acute wounds, 17 (95 per cent confidence interval (c.i.) 0.02 to 0.32) per cent more wounds appeared to heal with TNP; the number needed to treat was six. This was, however, at the cost of an 11 (95 per cent c.i. 0.01 to 0.21) per cent higher complication rate; the number needed to harm was nine. CONCLUSION There is little evidence to support the use of TNP in the treatment of wounds.
Collapse
Affiliation(s)
- D T Ubbink
- Department of Quality Assurance and Process Innovation, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
| | | | | | | |
Collapse
|
24
|
Abstract
BACKGROUND Topical silver treatments and silver dressings are increasingly used for the local treatment of contaminated or infected wounds, however, there is a lack of clarity regarding the evidence for their effectiveness. OBJECTIVES To evaluate the effects on wound healing of topical silver and silver dressings in the treatment of contaminated and infected acute or chronic wounds. SEARCH STRATEGY We sought relevant trials from the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Wounds Group Specialised Register in March 2006 and in MEDLINE, EMBASE, CINAHL, and digital dissertations databases up to September 2006. In addition, we contacted companies, manufacturers and distributors for information to identify relevant trials. SELECTION CRITERIA Randomised controlled trials (RCTs) assessing the effectiveness of topical silver in the treatment of contaminated and infected acute or chronic wounds. DATA COLLECTION AND ANALYSIS Eligibility of trials, assessment of trial quality and data extraction were undertaken by two authors independently. Disagreements were referred to a third author. MAIN RESULTS Three RCTs were identified, comprising a total of 847 participants. One trial compared silver-containing foam (Contreet) with hydrocellular foam (Allevyn) in patients with leg ulcers. The second trial compared a silver-containing alginate (Silvercel) with an alginate alone (Algosteril). The third trial compared a silver-containing foam dressing (Contreet)) with best local practice in patients with chronic wounds.The data from these trials show that silver-containing foam dressings did not significantly increase complete ulcer healing as compared with standard foam dressings or best local practice after up to four weeks of follow-up, although a greater reduction of ulcer size was observed with the silver-containing foam. The use of antibiotics was assessed in two trials, but no significant differences were found. Data on pain, patient satisfaction, length of hospital stay, and costs were limited and showed no differences. Leakage occurred significantly less frequently in patients with leg ulcers and chronic wounds treated with a silver dressing than with a standard foam dressing or best local practice in one trial. AUTHORS' CONCLUSIONS Only three trials with a short follow-up duration were found. There is insufficient evidence to recommend the use of silver-containing dressings or topical agents for treatment of infected or contaminated chronic wounds.
Collapse
Affiliation(s)
- H Vermeulen
- Academic Medical Centre, University of Amsterdam, Department of Surgery, Meibergdreef 9, PO Box 22700, Amsterdam, Netherlands, 1100 DE.
| | | | | | | |
Collapse
|
25
|
Ubbink DT, Vermeulen H, Lubbers MJ. [Local wound care: evidence-based treatments and dressings]. Ned Tijdschr Geneeskd 2006; 150:1165-72. [PMID: 16768278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
Patients with open wounds require specific local-wound care. There is huge variety in methods of local-wound care. This is due not only to the many different types of wounds but also to the widely varying preferences of doctors and nurses, and to the lack of strong evidence and relevant guidelines regarding the most appropriate form of local-wound care. In 19 systematic literature reviews from the Cochrane Collaboration on surgical and traumatic wounds and ulcers (venous, arterial and diabetic) information can be found on local-wound treatment. Eleven of these reviews were limited to strong evidence for the use of: tissue adhesives for surgical and traumatic wounds; foam dressings in surgical wounds healing by secondary intention; (intermittent) compression, bilayer artificial skin and lidocaine-prilocaine cream for venous ulcers; hydrogel and in-shoe orthotics for diabetic-foot ulcers; negative pressure for chronic wounds, and cleansing of acute wounds with clean tap water.
Collapse
Affiliation(s)
- D Th Ubbink
- Academisch Medisch Centrum/Universiteit van Amsterdam.
| | | | | |
Collapse
|
26
|
Vermeulen H, Ubbink D. Authors' reply: Systematic review of dressings and topical agents for surgical wounds healing by secondary intention (Br J Surg 2005; 92: 665-672). Br J Surg 2005. [DOI: 10.1002/bjs.5244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- H Vermeulen
- Department of Surgery, G4-233, Academic Medical Center, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands
| | - D Ubbink
- Department of Surgery, G4-233, Academic Medical Center, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands
| |
Collapse
|
27
|
Vermeulen H, Ubbink DT, Storm-Versloot MN. Topical silver for treating infected wounds. THE COCHRANE DATABASE OF SYSTEMATIC REVIEWS 2005. [DOI: 10.1002/14651858.cd005486] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
28
|
Abstract
BACKGROUND Patients suffering from inoperable chronic critical leg ischaemia (NR-CCLI), face amputation of the leg. Spinal cord stimulation (SCS) has been proposed as a helpful treatment in addition to standard conservative treatment. OBJECTIVES To find evidence for an improvement of limb salvage, pain relief and clinical situation using SCS compared to conservative treatment alone. SEARCH STRATEGY We searched the Cochrane Peripheral Vascular Diseases Group's Specialised Register, (last searched May 2005), and the Cochrane Central Register of Controlled Trials (CENTRAL) (last searched Issue 2, 2005). Additional data were obtained from research institutes. SELECTION CRITERIA Controlled studies comparing additional SCS with any form of conservative treatment in patients with NR-CCLI. DATA COLLECTION AND ANALYSIS Both authors independently assessed the quality of the studies and extracted data. MAIN RESULTS Six studies comprising nearly 450 patients were included. In general, the quality of the studies was good. None was blinded due to the nature of the intervention. Limb salvage after 12 months was significantly higher in the SCS group (relative risk (RR) 0.71, 95% confidence interval (CI) 0.56 to 0.90; risk difference (RD) -0.11, 95% CI -0.20 to -0.02). Significant pain relief occurred in both treatment groups, but was more prominent in the SCS group, in which the patients required significantly less analgesics. In the SCS group, significantly more patients reached Fontaine stage II than in the conservative group (RR 4.9, 95% CI 2.0 to 11.9; RD 0.33, 95% CI 0.19 to 0.47). Overall, no significantly different effect on ulcer healing was observed between the two treatments. Complications of SCS treatment consisted of implantation problems (9%, 95% CI 4 to 15%) and changes in stimulation requiring re-intervention (15%, 95% CI 10 to 20%). Infections of the lead or pulse generator pocket occurred less frequently (3%, 95% CI 0 to 6%). The overall risk of complications of additional SCS treatment was 17% (95% CI 12 to 22%), indicating a number needed to harm of 6 (95% CI 5 to 8).A cost comparison was made in only one study. The average overall costs at two years were 36,500 Euros, (SCS group) and 28,600 Euros, (conservative group). The difference (7900 Euros) was significant (P<0.009). AUTHORS' CONCLUSIONS There is evidence to favour SCS over standard conservative treatment to improve limb salvage and clinical situation in patients with NR-CCLI. The benefits of SCS against the possible harm of relatively mild complications and costs must be considered.
Collapse
Affiliation(s)
- D T Ubbink
- Department of Vascular Surgery, University of Amsterdam, J1b-215 Academic Medical Center, Meibergdreef 9, PO Box 22700, Amsterdam, Netherlands, 1100 DE.
| | | |
Collapse
|
29
|
Go HLS, Baarslag HJ, Vermeulen H, Laméris JS, Legemate DA. A comparative study to validate the use of ultrasonography and computed tomography in patients with post-operative intra-abdominal sepsis. Eur J Radiol 2005; 54:383-7. [PMID: 15899340 DOI: 10.1016/j.ejrad.2004.08.004] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2004] [Revised: 08/02/2004] [Accepted: 08/04/2004] [Indexed: 11/30/2022]
Abstract
PURPOSE To validate abdominal ultrasonography and helical computed tomography in detecting causes for sepsis in patients after abdominal surgery and to determine improved criteria for its use. MATERIALS AND METHODS Eighty-five consecutive surgical patients primarily operated for non-infectious disease were included in this prospective study. Forty-one patients were admitted to the intensive care unit. All patients were suspected of an intra-abdominal sepsis after abdominal surgery. Both ultrasonography (US) and helical abdominal computed tomography (CT) were performed to investigate the origin of an intra-abdominal sepsis. The images of both US and CT were interpreted on a four-point scale by different radiologists or residents in radiology, the investigators were blinded of each other's test. Interpretations of US and CT were compared with a reference standard which was defined by the result of diagnostic aspiration of suspected fluid collections, (re)laparotomy, clinical course or the opinion of an independent panel. Likelihood ratios and post-test probabilities were calculated and interobserver agreement was determined using kappa statistics. RESULTS The overall prevalence of an abdominal infection was 0.49. The likelihood ratio (LR) of a positive test-result for US was 1.33 (95% CI: 0.8-2.5) and for CT scan 2.53 (95% CI: 1.4-5.0); corresponding post-test probabilities for US 0.57 (95% CI: 0.42-0.70) and for CT 0.71 (95% CI: 0.57-0.83). The LR of a negative test-result was, respectively, 0.60 (95% CI: 0.3-1.3) and 0.18 (95% CI: 0.06-0.5); corresponding post-test probabilities for US 0.37 (95% CI: 0.20-0.57) and for CT 0.15 (95% CI: 0.06-0.32) were calculated. CONCLUSION Computed tomography can be used as the imaging modality of choice in patients suspected of intra-abdominal sepsis after abdominal surgery. Because of the low discriminatory power ultrasonography should not be performed as initial diagnostic test.
Collapse
Affiliation(s)
- H L S Go
- Department of Radiology, Academic Medical Center, University of Amsterdam, C-1, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands
| | | | | | | | | |
Collapse
|
30
|
Vermeulen H, Ubbink DT, Goossens A, de Vos R, Legemate DA. Systematic review of dressings and topical agents for surgical wounds healing by secondary intention. Br J Surg 2005; 92:665-72. [DOI: 10.1002/bjs.5055] [Citation(s) in RCA: 83] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Abstract
Background
The best dressing for postoperative wounds healing by secondary intention is unknown.
Methods
A systematic review was conducted to assess the effectiveness of dressings and topical agents on such wounds. Main endpoints were wound healing, pain, patient satisfaction, costs and hospital stay. Systematic methodological appraisal and data extraction were performed by independent reviewers.
Results
Fourteen reports of 13 randomized clinical trials on dressings or topical agents (gauze, foam, bead, alginate and hydrocolloid dressing) for postoperative wounds healing by secondary intention were identified; they were of weak methodological quality. In general, no statistically significant differences in wound healing were found for various dressing comparisons (11 of 13 trials). Patients experienced significantly more pain (four of six trials) and were less satisfied when gauze was used (three of six trials). Gauze was inexpensive, but its use was associated with significantly more nursing time than dressing with foam (two of three trials). No substantial differences in hospital stay were found (four of five trials).
Conclusions
Only small, poor-quality trials exist, rendering the evidence insufficient. Foam is best studied as an alternative to gauze and appears to be preferable in terms of pain reduction, patient satisfaction and nursing time.
Collapse
Affiliation(s)
- H Vermeulen
- Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands
| | - D T Ubbink
- Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands
- Department of Clinical Epidemiology and Biostatistics, Academic Medical Centre, Amsterdam, The Netherlands
| | - A Goossens
- Department of Clinical Epidemiology and Biostatistics, Academic Medical Centre, Amsterdam, The Netherlands
| | - R de Vos
- Department of Clinical Epidemiology and Biostatistics, Academic Medical Centre, Amsterdam, The Netherlands
| | - D A Legemate
- Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands
| |
Collapse
|
31
|
Ubbink DT, Vermeulen H, Spincemaille GHJJ, Gersbach PA, Berg P, Amann W. Systematic review and meta-analysis of controlled trials assessing spinal cord stimulation for inoperable critical leg ischaemia. Br J Surg 2004; 91:948-55. [PMID: 15286954 DOI: 10.1002/bjs.4629] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Abstract
Background
Spinal cord stimulation (SCS) may have a place in the treatment of patients with inoperable chronic critical leg ischaemia.
Methods
A systematic review and meta-analysis was performed of all controlled studies comparing SCS in addition to any form of conservative treatment for inoperable chronic critical leg ischaemia. Main endpoints were limb salvage, pain relief and clinical situation. Systematic methodological appraisal and data extraction were performed by independent reviewers.
Results
Of the 18 reports found, nine trials, comprising 444 patients, matched the selection criteria. After pooling, limb salvage at 12 months appeared significantly greater in the SCS group (risk difference (RD) − 0·13 (95 per cent confidence interval (c.i.) − 0·04 to − 0·22)). Significant pain relief occurred in both treatment groups, but patients who received SCS required significantly less analgesia and reached Fontaine stage 2 more often than those who did not have SCS (RD 0·33 (95 per cent c.i. 0·19 to 0·47)). Complications of SCS were problems of implantation (8·2 per cent), changes in stimulation requiring reintervention (14·8 per cent) and infection (2·9 per cent).
Conclusion
The addition of SCS to standard conservative treatment improves limb salvage, ischaemic pain and the general clinical situation in patients with inoperable chronic critical leg ischaemia. These benefits should be weighed against the cost and the (minor) complications associated with the technique.
Collapse
Affiliation(s)
- D T Ubbink
- Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.
| | | | | | | | | | | |
Collapse
|
32
|
Vermeulen H, Ubbink D, Goossens A, de Vos R, Legemate D. Surgical wounds healing by secondary intention: dressings and topical agents. J Tissue Viability 2004. [DOI: 10.1016/s0965-206x(04)42006-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
33
|
Baan AH, Vermeulen H, van der Meulen J, Bossuyt P, Olszyna D, Gouma DJ. The effect of suprapubic catheterization versus transurethral catheterization after abdominal surgery on urinary tract infection: a randomized controlled trial. Dig Surg 2003; 20:290-5. [PMID: 12789024 DOI: 10.1159/000071693] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2002] [Accepted: 01/01/2003] [Indexed: 12/13/2022]
Abstract
BACKGROUND/AIM Transurethral catheterization is generally associated with a higher incidence of urinary tract infections than suprapubic catheterization; however, suprapubic catheterization is associated with other disadvantages such as higher costs and a more difficult technique, and at the moment there is no consensus about the use of both catheter systems. Therefore, a prospective randomized study was performed to investigate the effects of suprapubic catheterization and transurethral catheterization in patients undergoing surgery on the incidence of urinary tract infections and patient satisfaction. METHODS Patients who underwent an elective laparotomy were randomized and received a suprapubic or transurethral catheter. The primary end point was urinary tract infection. Other parameters of urinary tract infection, as well as duration of catheterization, hospital stay, and number of recatheterizations and of relaparotomies were monitored. Treatment 'per protocol' was also analyzed after exclusion of patients receiving another catheter than randomized for. Patients were asked for their satisfaction with the catheters and complaints during and after catheterization. RESULTS 165 patients were eligible, of whom 19 patients had to be excluded. 75 patients were allocated to receive the suprapubic catheter and 71 the transurethral catheter. There was no difference in the incidence of a urinary tract infection between the suprapubic group (n = 9/75; 12%) and the transurethral group (n = 8/71; 11%). Most patients (6/9) who developed a urinary tract infection in the suprapubic group, however, underwent recatheterization because of postoperative complications/sepsis and relaparotomy. The incidence of urinary tract infections in patients who received a suprapubic catheter and not a transurethral catheter was 3/59 (5%). The patients did not differ with respect to satisfaction and complaints. Being a men, recatheterization and duration of catheterization are risk factors. CONCLUSIONS The incidence of a urinary tract infection between a suprapubic catheter and a transurethral catheter in patients undergoing major surgery was not different. A potential advantage of the suprapubic catheter (reduction of urinary tract infections) is probably partly negated, because transurethral catheters were used if recatheterization was indicated during the postoperative stay or due to complications.
Collapse
Affiliation(s)
- A H Baan
- Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands
| | | | | | | | | | | |
Collapse
|
34
|
Abstract
BACKGROUND Patients suffering from inoperable chronic critical leg ischaemia (NR-CCLI), face amputation of the leg. Spinal cord stimulation (SCS) has been proposed as a helpful treatment in addition to standard conservative treatment. OBJECTIVES To find evidence for an improvement of limb salvage, pain relief and clinical situation by means of SCS over conservative treatment alone. SEARCH STRATEGY The reviewers searched the Cochrane Peripheral Vascular Diseases Group Specialised Register, (last searched November 2002), the Cochrane Central Register of Controlled Trials (CENTRAL) (last searched Issue 4, 2002). Additional data were obtained from research institutes. SELECTION CRITERIA Controlled studies comparing additional SCS with any form of conservative treatment in patients with NR-CCLI. DATA COLLECTION AND ANALYSIS Two reviewers (DU, HV), independently assessed the quality of the studies and extracted the data. MAIN RESULTS Six studies comprising nearly 450 patients were included. In general the quality of the studies was good, although none of them was blinded due to the nature of the intervention. Limb salvage after 12 months was significantly higher in the SCS group (RR 0.71, 95%CI: 0.56 to 0.90; RD -0.13, 95%CI: -0.22 to -0.04). Significant pain relief occurred in both treatment groups, but was more prominent in the SCS group, in which the patients required significantly less analgesics. In the SCS group significantly more patients reached Fontaine stage II than in the conservative group (RR 4.9, 95%CI: 2.0 to 11.9; RD 0.33, 95%CI: 0.19 to 0.47). Overall, no significantly different effect on ulcer healing was observed between the two treatments. Complications of SCS treatment consisted of implantation problems (9%; 95%CI: 4 to 15%) and changes in stimulation requiring reintervention, (15%; 95%CI: 10 to 20%). Infections of the lead or pulse generator pocket occurred less frequently (3%; 95%CI: 0 to 6%). The overall risk of complications of additional SCS treatment was 17%, 95%CI: 12 to 22%, indicating a number needed to harm of six (95%CI: 5 to 8).A cost comparison was made in only one study. The average overall costs at two years were 36,500 euros, in the SCS group and 28,600 euros, in the conservative group. The difference (7,900 euros) was significant (p<0.009). REVIEWER'S CONCLUSIONS There is evidence to favour SCS over standard conservative treatment to improve limb salvage and clinical situation in patients with NR-CCLI. The benefits of SCS against the possible harm of relatively mild complications, and costs must be considered.
Collapse
Affiliation(s)
- D T Ubbink
- Vascular Surgery, Academic Medical Centre Amsterdam, Meibergdreef 9, P.O. Box 22700, Amsterdam, Netherlands
| | | |
Collapse
|
35
|
Olszyna DP, Vermeulen H, Baan AH, Speelman P, van Deventer SJ, Gouma DJ, van der Poll T. Urine interleukin-8 is a marker for urinary tract infection in postoperative patients. Infection 2001; 29:274-7. [PMID: 11688906 DOI: 10.1007/s15010-001-1157-z] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
BACKGROUND Urine of patients with urinary tract infection (UTI) contains high levels of interleukin (IL)-6 and IL-8. However, knowledge of the kinetics of their release in urine is limited. We therefore compared the appearance of IL-6 and IL-8 in urine after uncomplicated surgery and surgery complicated by UTI. PATIENTS AND METHODS 165 patients undergoing abdominal surgery who received a urinary catheter were studied. Urine IL-6 and IL-8 were prospectively measured in patients who did (n = 10) or did not (n = 20) develop UTI. Statistical analysis was done by one-way ANOVA and the Mann-Whitney test. RESULTS Although urine IL-6 increased in the 2 to 4 days preceding the bacteriological documentation of UTI, a similar increase was observed in patients who did not develop UTI. Urine IL-8 was elevated on the day UTI was diagnosed, while remaining low in controls. CONCLUSION In this patient group with postoperative UTI, urine IL-8 was a better marker for the early host response than urine IL-6.
Collapse
Affiliation(s)
- D P Olszyna
- Dept. of Experimental Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
| | | | | | | | | | | | | |
Collapse
|
36
|
van Egmond M, van Spriel AB, Vermeulen H, Huls G, van Garderen E, van de Winkel JG. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89). Cancer Res 2001; 61:4055-60. [PMID: 11358825] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/16/2023]
Abstract
Antibodies can efficiently induce antitumor responses via recruitment of Fc receptor-bearing cytotoxic cells. Polymorphonuclear (PMN) cells represent attractive effector cells for antibody-directed immunotherapy. This, because activated PMN cells coexpress the class I receptors for IgG (FcgammaRI, CD64) and IgA (FcalphaRI, CD89), which are potent cytotoxic trigger molecules. Both receptors, however, require the FcR gamma chain for signaling. In this study, we show that FcgammaRI and FcalphaRI can trigger function independently of one another and do not cross-compete for the FcR gamma chain. FcalphaRI proved more efficient in initiating early signaling events and effector functions, such as redirected tumor cell killing and generation of superoxide. In addition, simultaneous engagement of FcgammaRI and FcalphaRI resulted in enhanced tumor cell lysis. These data support the development of concepts in which both FcgammaRI and FcalphaRI on PMN cells are targeted for tumor therapy.
Collapse
MESH Headings
- Animals
- Antigens, CD/biosynthesis
- Antigens, CD/genetics
- Antigens, CD/immunology
- Breast Neoplasms/immunology
- Cytotoxicity, Immunologic/immunology
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology
- Humans
- Male
- Mice
- Multiple Myeloma/immunology
- Neutrophils/drug effects
- Neutrophils/immunology
- Receptors, Fc/biosynthesis
- Receptors, Fc/genetics
- Receptors, Fc/immunology
- Receptors, IgG/biosynthesis
- Receptors, IgG/genetics
- Receptors, IgG/immunology
- Signal Transduction/immunology
- Tumor Cells, Cultured
- Tumor Necrosis Factor-alpha/pharmacology
- Up-Regulation
Collapse
Affiliation(s)
- M van Egmond
- Department of Cell Biology/Immunology, Vrije Universiteit, Amsterdam, the Netherlands
| | | | | | | | | | | |
Collapse
|
37
|
De Bruijn ML, Greenstone HL, Vermeulen H, Melief CJ, Lowy DR, Schiller JT, Kast WM. L1-specific protection from tumor challenge elicited by HPV16 virus-like particles. Virology 1998; 250:371-6. [PMID: 9792847 DOI: 10.1006/viro.1998.9372] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
A single injection of HPV16 L1 virus-like particles induced potent CD8-mediated protection from tumor challenge by C3 cells, a line derived from embryonic mouse cells transfected with the HPV16 genome. L1 RNA, but not protein, was detected biochemically in C3 cells. These results indicate that low-level expression of HPV16 L1 can occur in proliferating cells and serve as a tumor vaccine target. Although L1 expression is generally thought to be restricted to terminally differentiated epithelial cells, these results suggest that additional analysis for low-level L1 expression in proliferating cells of HPV-induced lesions is warranted and might help in predicting the clinical potential of HPV L1 virus-like particle-based vaccines.
Collapse
Affiliation(s)
- M L De Bruijn
- Department of Immunohematology and Blood Bank, University Hospital Leiden, Building 1, E3-Q, Leiden, 2300 RC, The Netherlands
| | | | | | | | | | | | | |
Collapse
|
38
|
De Bruijn ML, Schuurhuis DH, Vierboom MP, Vermeulen H, de Cock KA, Ooms ME, Ressing ME, Toebes M, Franken KL, Drijfhout JW, Ottenhoff TH, Offringa R, Melief CJ. Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells. Cancer Res 1998; 58:724-31. [PMID: 9485027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Human papillomavirus (HPV) E6 and E7 oncoproteins are attractive targets for T-cell-based immunotherapy of cervical cancer. In this study, we demonstrate that dendritic cells (DCs) pulsed with HPV16 E7 protein are not only recognized in vitro by E7-specific CTLs but also elicit E7-specific CTL responses in vivo, associated with protection against a challenge with syngeneic HPV16-induced tumor cells. Vaccination with soluble E7 protein in incomplete Freund's adjuvant likewise induces E7-specific CTL responses associated with tumor protection. The presence of HPV16 E7-specific CTLs in vivo and the observation that depletion of CD8+ cells completely abolishes tumor protection demonstrate that CTLs are the major effector cells in mediating antitumor activity. The in vivo involvement of DCs in the activation of protective CTLs is suggested by the surface display of E7 peptide-loaded MHC class I molecules on these cells after E7 protein immunization. These data show that HPV16 E7 protein-pulsed DCs, as well as the administration of E7 protein antigen in adjuvant, can effectively stimulate tumor-specific MHC class I-restricted CD8+ T-cell-mediated protective immunity to HPV16-induced cancers.
Collapse
Affiliation(s)
- M L De Bruijn
- Department of Immunohematology and Blood Bank, University Hospital Leiden, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
De Bruijn M, Greenstone H, Vermeulen H, Melief C, Schiller J, Kast W. Immunization with HPV16 virus-like particles protects mice against a challenge with HPV16-induced tumor cells. Immunol Lett 1997. [DOI: 10.1016/s0165-2478(97)86186-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
40
|
De Bruijn ML, Schuurhuis DH, Vermeulen H, de Cock KA, Melief CJ. Processing of exogenous protein antigen by murine dendritic cells for presentation to cytotoxic T lymphocytes. Adv Exp Med Biol 1997; 417:213-20. [PMID: 9286364 DOI: 10.1007/978-1-4757-9966-8_36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- M L De Bruijn
- Department of Immunohematology and Bloodbank, University Hospital Leiden, The Netherlands
| | | | | | | | | |
Collapse
|
41
|
Hilkens C, Snijders A, Vermeulen H, van der Meide P, Wierenga E, Kapsenberg M. Accessory cell-derived interleukin-12 and prostaglandin E2 determine the level of interferon-gamma produced by activated human CD4+ T cells. Ann N Y Acad Sci 1996; 795:349-50. [PMID: 8958951 DOI: 10.1111/j.1749-6632.1996.tb52689.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- C Hilkens
- Department of Cell Biology and Histology, University of Amsterdam, The Netherlands
| | | | | | | | | | | |
Collapse
|
42
|
Abstract
In a previous study, accumulation of methane was found at the end of closed-system ventilation. As on-line analysis of gas concentrations is now available, we examined the progressive increase in concentrations of methane, carbon monoxide and acetone during modern, closed-system conditions, and their influence on infrared halothane analysis, in 26 non-pregnant, gynaecological patients. A computer-controlled closed-system anaesthesia apparatus (PhysioFlex) was used for ventilation during total i.v. anaesthesia (excluding nitrous oxide or potent inhalation anaesthetics) for gynaecological laparoscopy. Methane, carbon monoxide and acetone concentrations were analysed every 15 min in a photoacoustic infrared monitor and halothane concentrations by built-in infrared spectrometry. Mean methane concentrations increased progressively after 105 min to 941 (SD 1094) ppm, but concentrations of carbon monoxide and acetone did not increase significantly. In 18 patients, the infrared measurement falsely indicated 0.79 (0.52)% "halothane" after 60 min, but no reading appeared in the other eight patients. We conclude that methane accumulated progressively under strict closed-system conditions in higher concentrations than reported previously. In two-thirds of patients it induced false "halothane" readings.
Collapse
Affiliation(s)
- L Versichelen
- Department of Anaesthesia, University Hospital, Ghent, Belgium
| | | | | |
Collapse
|
43
|
Hilkens CM, Snijders A, Vermeulen H, van der Meide PH, Wierenga EA, Kapsenberg ML. Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-gamma level of activated human CD4+ T cells. The Journal of Immunology 1996. [DOI: 10.4049/jimmunol.156.5.1722] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Abstract
IL-12 and PGE2 are two immunomodulators produced by accessory cells (AC) in response to various stimuli. IL- 12 enhances IFN-gamma production by activated CD4+ T cells, whereas PGE2 inhibits the secretion of this cytokine. Because these AC-derived factors exert clearly opposite modulatory effects on IFN-gamma production, we examined 1) the net-IFN-gamma production of CD4+ T cells, stimulated in the presence of both IL-12 and PGE2, 2) the susceptibility of activated CD4+ T cells in time by adding these modulators at different timepoints after stimulation, and 3) the relative contributions of AC-derived IL-12 and PGE2 to IFN-gamma levels by stimulating CD4+ T cells in the presence of LPS-activated monocytes and inhibitors of PGE2 or IL-12. Here, we demonstrate that 1) IL-12 and PGE2 do not abrogate the modulatory action of each other and that the net-IFN-gamma production is determined by their concentration ratio, 2) T cells become insensitive to PGE2, whereas susceptibility to IL-12 is retained after activation, and 3) activated monocytes potently modulate IFN-gamma levels of stimulated CD4+ T cells via release of IL-12 and PGE2. The relative contributions of these AC-derived factors shift in time, due to different production kinetics, from a dominant IL-12 effect to a mixed IL-12/PGE2 effect. Because the net IFN-gamma production of CD4+ T cells is largely determined by the ratio of IL-12 and PGE2 at the timepoint of T cell activation, an imbalance in the production of these immunomodulators may, therefore, lead to immunologic dysfunction.
Collapse
Affiliation(s)
- C M Hilkens
- Department of Cell Biology and Histology, Academic Medical Center, Amsterdam, The Netherlands
| | - A Snijders
- Department of Cell Biology and Histology, Academic Medical Center, Amsterdam, The Netherlands
| | - H Vermeulen
- Department of Cell Biology and Histology, Academic Medical Center, Amsterdam, The Netherlands
| | - P H van der Meide
- Department of Cell Biology and Histology, Academic Medical Center, Amsterdam, The Netherlands
| | - E A Wierenga
- Department of Cell Biology and Histology, Academic Medical Center, Amsterdam, The Netherlands
| | - M L Kapsenberg
- Department of Cell Biology and Histology, Academic Medical Center, Amsterdam, The Netherlands
| |
Collapse
|
44
|
Hilkens CM, Snijders A, Vermeulen H, van der Meide PH, Wierenga EA, Kapsenberg ML. Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-gamma level of activated human CD4+ T cells. J Immunol 1996; 156:1722-27. [PMID: 8596019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
IL-12 and PGE2 are two immunomodulators produced by accessory cells (AC) in response to various stimuli. IL- 12 enhances IFN-gamma production by activated CD4+ T cells, whereas PGE2 inhibits the secretion of this cytokine. Because these AC-derived factors exert clearly opposite modulatory effects on IFN-gamma production, we examined 1) the net-IFN-gamma production of CD4+ T cells, stimulated in the presence of both IL-12 and PGE2, 2) the susceptibility of activated CD4+ T cells in time by adding these modulators at different timepoints after stimulation, and 3) the relative contributions of AC-derived IL-12 and PGE2 to IFN-gamma levels by stimulating CD4+ T cells in the presence of LPS-activated monocytes and inhibitors of PGE2 or IL-12. Here, we demonstrate that 1) IL-12 and PGE2 do not abrogate the modulatory action of each other and that the net-IFN-gamma production is determined by their concentration ratio, 2) T cells become insensitive to PGE2, whereas susceptibility to IL-12 is retained after activation, and 3) activated monocytes potently modulate IFN-gamma levels of stimulated CD4+ T cells via release of IL-12 and PGE2. The relative contributions of these AC-derived factors shift in time, due to different production kinetics, from a dominant IL-12 effect to a mixed IL-12/PGE2 effect. Because the net IFN-gamma production of CD4+ T cells is largely determined by the ratio of IL-12 and PGE2 at the timepoint of T cell activation, an imbalance in the production of these immunomodulators may, therefore, lead to immunologic dysfunction.
Collapse
Affiliation(s)
- C M Hilkens
- Department of Cell Biology and Histology, Academic Medical Center, Amsterdam, The Netherlands
| | | | | | | | | | | |
Collapse
|
45
|
Affiliation(s)
- C van Weel
- Department of General Practice and Social Medicine, University of Nijmegen, Netherlands
| | | | | |
Collapse
|
46
|
Hilkens CM, Vermeulen H, van Neerven RJ, Snijdewint FG, Wierenga EA, Kapsenberg ML. Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur J Immunol 1995; 25:59-63. [PMID: 7843254 DOI: 10.1002/eji.1830250112] [Citation(s) in RCA: 146] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Prostaglandin E2 (PGE2) favors T helper type 2 (Th2)-like cytokine secretion profiles in murine and human CD4+ T cells by inhibiting the production of the Th1-associated cytokines interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) and up-regulating the production of the Th2-associated cytokines IL-4 and IL-5 in a dose-dependent way. However, the potent inhibition of IL-2 production by PGE2 seems to be in contrast with the simultaneous up-regulation of IL-4 and IL-5 production, because the induction of these cytokines requires IL-2. We, therefore, investigated to which extent the net modulatory effect of PGE2 is determined by the availability of IL-2. To this aim, we examined the effects of PGE2 on the cytokine secretion profiles of a panel of human Th0 clones upon stimulation via different activation pathways, resulting either in high or low IL-2 production. The differential modulation of Th1 and Th2 cytokines by PGE2 was observed only upon modes of stimulation resulting in high IL-2 production. When IL-2 production was low, PGE2 inhibited the secretion of all four cytokines. These different modulation patterns were directly related to the IL-2 availability, because (i) neutralizing antibody to IL-2 abrogated the up-regulatory effect of PGE2 on IL-4 and IL-5 secretion in experiments with high endogenous IL-2 levels, (ii) lack of differential cytokine modulation by PGE2 in conditions with low levels of endogenous IL-2 could be restored with exogenous IL-2, and (iii) cell viability was comparable in all conditions. These results demonstrate that the net modulatory effect of PGE2 on the cytokine secretion profile of T cells critically depends on the availability of IL-2. Since this parameter varies with the experimental conditions and the T cell population studied, this finding may explain why certain immune responses may be either up- or down-regulated by PGE2 under different conditions.
Collapse
Affiliation(s)
- C M Hilkens
- Department of Cell Biology and Histology, University of Amsterdam, The Netherlands
| | | | | | | | | | | |
Collapse
|
47
|
Abstract
The adjuvant effect of interleukin 6 (IL-6) entrapped in liposomes was evaluated using a 65 kDa heat shock protein as a model antigen. The secondary humoral immune response either to antigen alone, or incorporated into liposomes, and the effect of IL-6 entrapped in liposomes, on this response were studied in Balb/c mice. The adjuvanticity of these formulations was compared with that of potent adjuvants such as Ribi and dimethyldioctadecylammoniumbromide (DDA). The importance of IL-6 during adjuvant activity was supported by the observation that high serum IL-6 levels were induced in Balb/c mice by all members of a panel of adjuvants tested. Following incorporation into liposomes, IL-6 retained its full biological activity, as shown by its capacity to sustain growth of the IL-6-dependent B9 cell line. At antigen dosages where Ribi and DDA gave minimal or no secondary antibody titres, incorporation of antigen into liposomes resulted in measurable secondary antibody titres. Interestingly, this adjuvant activity was significantly enhanced when liposomes containing IL-6 were co-injected with the liposomal antigen formulation. These results illustrate the potential adjuvant properties of this formulation, which seem especially useful for vaccines containing weak or non-immunogenic antigens.
Collapse
Affiliation(s)
- A J Duits
- Department of Immunology, University Hospital Utrecht, The Netherlands
| | | | | | | | | | | |
Collapse
|
48
|
Dutre P, Rolly G, Vermeulen H. Effect of intravenous hypnotics on the actions of pipecuronium. Ugeskr Laeger 1992; 9:313-7. [PMID: 1321037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Seventy-five ASA Grades I-III patients (18-85 years, 45-90 kg) were randomized into five groups. All patients received N2O/O2 (2/1) and alfentanil: loading dose (LD) 0.015 mg kg-1 and maintenance dose (MD) 0.045 mg kg-1 h-1 (groups 1-4). Group 1 received propofol (LD 2 mg kg-1 and MD 6 mg kg-1 h-1); Group 2 etomidate (LD 0.3 mg kg-1 and MD 0.6 mg kg-1 h-1); Group 3 midazolam (LD 0.2 mg kg-1 and MD 0.120 mg kg-1 h-1); Group 4 methohexitone (LD 1.5 mg kg-1 and MD 4 mg kg-1 h-1); Group 5 dehydrobenzperidol 0.05-0.23 mg kg-1 and alfentanil (LD 0.100 mg kg-1 and MD 0.060 mg kg-1 h-1). The neuromuscular block induced by pipecuronium (50 micrograms kg-1) was evaluated. No statistically significant differences were found between the five groups as concerned degree of block (expressed as % twitch amplitude in response to the first of the TOF stimuli (Ta1) at intubation, T1 minimum and recovery to Ta1 = 20%, 25% and 75%. Slightly faster intubation was possible when midazolam was used in comparison with propofol, methohexitone or NLA and when etomidate was used in comparison with propofol. A wide range of individual values of maximal neuromuscular blocking activity was found.
Collapse
Affiliation(s)
- P Dutre
- Department of Anaesthesiology, University Hospital, Gent, Belgium
| | | | | |
Collapse
|
49
|
|
50
|
van Tits M, Vermeulen H. [Developments in the labor market (5). Community health nursing and homemaking services]. TVZ 1992:104-7. [PMID: 1540329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|